The purpose of this webinar is to enable participants to increase their knowledge of the usage rates and effects that methamphetamine has on HIV risk and HIV disease progression.
Upon completion, participants will be able to:
- Discuss the clinical effects of methamphetamines on PLWH
- Describe intervention strategies designed for PLWH who use methamphetamines
Speaker
Valerie Gruber, PhD, MPH
Professor
Department of Psychiatry
University of California, San Francisco
Accreditation
PSNA: The MidAtlantic AIDS Education and Training Center is an approved provider of continuing education by the Pennsylvania State Nurses Association, an accredited approver by the American Nurses Credentialing Center’s Commission on Accreditation.
This activity qualifies for 1.0 contact hours.
CME: This activity has been planned and implemented in accordance with the accreditation requirements and policies of the Accreditation Council for Continuing Medical Education (ACCME) through the joint providership of University of Pittsburgh School of Medicine and MidAtlantic AIDS Education and Training Center. The University of Pittsburgh School of Medicine accredited by the ACCME to provide continuing medical education for physicians.
The University of Pittsburgh School of Medicine designates this live activity for a maximum of 1.0 AMA PRA Category 1 Credits™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.
Other health care profesionals are awarded 0.1 continuing education units (CEU's) which are equal to 1.0 contact hours.
CEU: The MidAtlantic AIDS Education and Training Center, Department of Infectious Diseases and Microbiology, University of Pittsburgh, awards Continuing Education Units to individuals who enroll in certain educational activities. This program is awarded 0.10 continuing education
credits.
